FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385178005: Conventional release vaginal tablet (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479441013 Vaginal tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3537394010 Conventional release vaginal tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3537395011 Conventional release vaginal tablet (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
28291000188118 comprimé vaginal fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vaginal tablet Is a Vaginal dose form (dose form) true Inferred relationship Some
Vaginal tablet Is a A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
Vaginal tablet Has dose form administration method (attribute) A method of administration of a dose form by being placed into a body cavity. true Inferred relationship Some
Vaginal tablet Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration to the vagina. true Inferred relationship Some
Vaginal tablet Has dose form release characteristic (attribute) A release characteristic where a dose form displays a rate and time of release of the active substance(s) in the dose form based on their intrinsic properties. true Inferred relationship Some
Vaginal tablet Has basic dose form (attribute) A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. true Inferred relationship Some
Vaginal tablet Has dose form transformation (attribute) No transformation true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Effervescent vaginal tablet Is a True Vaginal tablet Inferred relationship Some
Dinoprostone 3 mg vaginal tablet Has manufactured dose form True Vaginal tablet Inferred relationship Some
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet Has manufactured dose form True Vaginal tablet Inferred relationship Some
Clotrimazole 500 mg vaginal tablet Has manufactured dose form True Vaginal tablet Inferred relationship Some
Product containing precisely estradiol 25 microgram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Vaginal tablet Inferred relationship Some
Nystatin 100000 unit vaginal tablet Has manufactured dose form True Vaginal tablet Inferred relationship Some
Progesterone 100 mg vaginal tablet Has manufactured dose form True Vaginal tablet Inferred relationship Some
Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Vaginal tablet Inferred relationship Some
Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Vaginal tablet Inferred relationship Some
Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Vaginal tablet Inferred relationship Some
Misoprostol 25 microgram vaginal tablet Has manufactured dose form True Vaginal tablet Inferred relationship Some
Misoprostol 100 microgram vaginal tablet Has manufactured dose form True Vaginal tablet Inferred relationship Some
Product containing precisely misoprostol 200 microgram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Vaginal tablet Inferred relationship Some
Product containing precisely estradiol 10 microgram/1 each conventional release vaginal tablet (clinical drug) Has manufactured dose form True Vaginal tablet Inferred relationship Some

This concept is not in any reference sets

Back to Start